Bayesian modelling for COVID-19 seroprevalence studies

Por um escritor misterioso
Last updated 10 novembro 2024
Bayesian modelling for COVID-19 seroprevalence studies
Bayesian modelling for COVID-19 seroprevalence studies
A note on COVID-19 seroprevalence studies: a meta-analysis using hierarchical modelling
Bayesian modelling for COVID-19 seroprevalence studies
Variation in the COVID-19 infection–fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis - The Lancet
Bayesian modelling for COVID-19 seroprevalence studies
Adjusting COVID-19 seroprevalence survey results to account for test sensitivity and specificity
Bayesian modelling for COVID-19 seroprevalence studies
Socioeconomic status determines COVID-19 incidence and related mortality in Santiago, Chile
Bayesian modelling for COVID-19 seroprevalence studies
Resurgence of SARS-CoV-2: Detection by community viral surveillance
Bayesian modelling for COVID-19 seroprevalence studies
Estimating the COVID-19 infection fatality ratio accounting for seroreversion using statistical modelling
Bayesian modelling for COVID-19 seroprevalence studies
Estimating SARS-CoV-2 seroprevalence and epidemiological parameters with uncertainty from serological surveys
Bayesian modelling for COVID-19 seroprevalence studies
Using test positivity and reported case rates to estimate state-level COVID-19 prevalence and seroprevalence in the United States
Bayesian modelling for COVID-19 seroprevalence studies
IJERPH, Free Full-Text
Bayesian modelling for COVID-19 seroprevalence studies
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

© 2014-2024 galemiami.com. All rights reserved.